Your browser doesn't support javascript.
loading
The shieldin complex mediates 53BP1-dependent DNA repair.
Noordermeer, Sylvie M; Adam, Salomé; Setiaputra, Dheva; Barazas, Marco; Pettitt, Stephen J; Ling, Alexanda K; Olivieri, Michele; Álvarez-Quilón, Alejandro; Moatti, Nathalie; Zimmermann, Michal; Annunziato, Stefano; Krastev, Dragomir B; Song, Feifei; Brandsma, Inger; Frankum, Jessica; Brough, Rachel; Sherker, Alana; Landry, Sébastien; Szilard, Rachel K; Munro, Meagan M; McEwan, Andrea; Goullet de Rugy, Théo; Lin, Zhen-Yuan; Hart, Traver; Moffat, Jason; Gingras, Anne-Claude; Martin, Alberto; van Attikum, Haico; Jonkers, Jos; Lord, Christopher J; Rottenberg, Sven; Durocher, Daniel.
Afiliação
  • Noordermeer SM; Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada.
  • Adam S; Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands.
  • Setiaputra D; Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada.
  • Barazas M; Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada.
  • Pettitt SJ; Division of Molecular Pathology, Oncode Institute, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Ling AK; The CRUK Gene Function Laboratory and Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.
  • Olivieri M; Department of Immunology, University of Toronto, Toronto, Ontario, Canada.
  • Álvarez-Quilón A; Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada.
  • Moatti N; Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
  • Zimmermann M; Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada.
  • Annunziato S; Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada.
  • Krastev DB; Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada.
  • Song F; Division of Molecular Pathology, Oncode Institute, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Brandsma I; The CRUK Gene Function Laboratory and Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.
  • Frankum J; The CRUK Gene Function Laboratory and Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.
  • Brough R; The CRUK Gene Function Laboratory and Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.
  • Sherker A; The CRUK Gene Function Laboratory and Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.
  • Landry S; The CRUK Gene Function Laboratory and Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.
  • Szilard RK; Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada.
  • Munro MM; Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
  • McEwan A; Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada.
  • Goullet de Rugy T; Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada.
  • Lin ZY; Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada.
  • Hart T; Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada.
  • Moffat J; Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada.
  • Gingras AC; Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada.
  • Martin A; Department of Bioinformatics and Computational Biology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • van Attikum H; Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
  • Jonkers J; Donnelly Centre, University of Toronto, Toronto, Ontario, Canada.
  • Lord CJ; Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada.
  • Rottenberg S; Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
  • Durocher D; Department of Immunology, University of Toronto, Toronto, Ontario, Canada.
Nature ; 560(7716): 117-121, 2018 08.
Article em En | MEDLINE | ID: mdl-30022168
53BP1 is a chromatin-binding protein that regulates the repair of DNA double-strand breaks by suppressing the nucleolytic resection of DNA termini1,2. This function of 53BP1 requires interactions with PTIP3 and RIF14-9, the latter of which recruits REV7 (also known as MAD2L2) to break sites10,11. How 53BP1-pathway proteins shield DNA ends is currently unknown, but there are two models that provide the best potential explanation of their action. In one model the 53BP1 complex strengthens the nucleosomal barrier to end-resection nucleases12,13, and in the other 53BP1 recruits effector proteins with end-protection activity. Here we identify a 53BP1 effector complex, shieldin, that includes C20orf196 (also known as SHLD1), FAM35A (SHLD2), CTC-534A2.2 (SHLD3) and REV7. Shieldin localizes to double-strand-break sites in a 53BP1- and RIF1-dependent manner, and its SHLD2 subunit binds to single-stranded DNA via OB-fold domains that are analogous to those of RPA1 and POT1. Loss of shieldin impairs non-homologous end-joining, leads to defective immunoglobulin class switching and causes hyper-resection. Mutations in genes that encode shieldin subunits also cause resistance to poly(ADP-ribose) polymerase inhibition in BRCA1-deficient cells and tumours, owing to restoration of homologous recombination. Finally, we show that binding of single-stranded DNA by SHLD2 is critical for shieldin function, consistent with a model in which shieldin protects DNA ends to mediate 53BP1-dependent DNA repair.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Complexos Multiproteicos / Reparo do DNA / Proteína 1 de Ligação à Proteína Supressora de Tumor p53 Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Complexos Multiproteicos / Reparo do DNA / Proteína 1 de Ligação à Proteína Supressora de Tumor p53 Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article